Volume 29, Number 6—June 2023
Dispatch
MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination
Christian Meyer zu Natrup, Lisa-Marie Schünemann, Giulietta Saletti, Sabrina Clever, Vanessa Herder, Sunitha Joseph, Marina Rodriguez, Ulrich Wernery, Gerd Sutter, and Asisa Volz
Table 1
MERS-CoV seroprevalence in 12 dromedary camels before vaccination, Dubai, United Arab Emirates*
| Camel ID | Optical density ratio (ELISA) | MERS-CoV infection status/cohort |
|---|---|---|
| 1 | 0.07 | Naive |
| 2 | 2.09 | Seropositive |
| 3 | 2.97 | Seropositive |
| 4 | 4.00 | Seropositive |
| 5 | 0.06 | Naive |
| 6 | 0.07 | Naive |
| 7 | 0.05 | Naive |
| 8 | 4.11 | Seropositive |
| 9 | 3.42 | Seropositive |
| 10 | 4.59 | Seropositive |
| 11 | 2.48 | Seropositive |
| 12 | 3.22 | Seropositive |
*ID, identification; MERS-CoV, Middle East respiratory syndrome coronavirus.
Page created: March 29, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.